Decro Pharma Pvt. Ltd. (DPPL) is a leading pharmaceutical company in India, founded in 2020. With a multi-crore turnover, it is equipped with state-of-the-art facilities that adhere to Schedule M GMP, WHO cGMP, EU GMP, and PICS guidelines. The company has established partnerships with several MNCs and boasts an impressive product pipeline in the industry today.
Mission
"Our mission is to be a global leader in providing innovative, high-quality, and cost-effective API and Formulation to the pharmaceutical industry while maintaining the highest standards of quality, compliance, and Lyophilisation competency in all of our operations, and constantly strive for sustainable growth."
Vision
"We envision a future where our innovative research and world-class manufacturing practices improve the lives of people worldwide through access to high-quality, safe, and effective drugs, while constantly striving for sustainable growth and being recognized as a leader in the global pharmaceutical industry."
We have state-of-the-art facilities for manufacturing Active Pharmaceutical Ingredients (APIs) and capabilities for research and development. We are committed to producing and providing high-quality generic products, including APIs, non-sterile bulk drugs, sterile lyophilized bulk drugs, and dry injection, lyophilization unit vials, and SVP liquid injection vial line formulations for the Indian and global markets.
Directors
- Rakesh Ambalal Patel
- Narendra Rajdev Pandey
- Bhikan Nimba Patil
- Hareshbhai Kalabhai Patel
- Sangitaben Rakeshkumar Patel
- Arvindbhai Patel
We are dedicated to continuously improving quality systems and compliance with environmental and safety regulations while expanding our capacities and supporting infrastructure. This has enabled us to service various customer projects and grow our generic business.
With a portfolio of more than 100 products catering to various therapeutic areas, we plan to maintain steady growth through disciplined execution by our highly qualified and experienced team.
We have also established a research and development (R&D) department with a team of highly skilled and qualified individuals who assist in continually improving processes and achieving a leadership position in the market for many of our products. We ensure that our methods are safe, sustainable, and cost-effective while maintaining the highest quality standards in our products.
What we care about.
Quality first
Precision-engineered machines manufactured with strict quality standards and attention to every detail.
Reliable performance
Built for consistent performance, dependable operation and demanding pharmaceutical production environments.
Precision engineering
Every component is developed with accuracy, stability and long-term machine performance in mind.
Customer focused
Technical support and machine solutions designed around your production requirements and applications.
How we got here.
The beginning
Bald Eagle Corporation begins its journey in pharmaceutical machinery manufacturing.
Building solutions
Continued development of advanced tablet compression machinery with a focus on precision and reliability.
Growing our capabilities
Strengthening product capabilities and manufacturing expertise to meet evolving industry requirements.
Engineering the future
Delivering reliable tablet press solutions while continuing to innovate for modern manufacturing.
The people behind Bald Eagle.
A dedicated team focused on precision engineering, reliable manufacturing and long-term customer relationships.
Certificates
